Echographic tricky aspects in the athlete's heart

Similar documents
Hypertrophic Cardiomyopathy or «Athlete s Heart»

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Cardiac hypertrophy : differentiating disease from athlete

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes

Athlete s Heart vs. Cardiomyopathy

Echo Evaluation of the Heart of an Athlete

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging?

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

Athletes with cardiac disease; dead and buried or chance for resurrection?

Key wards: PR Interval, QT interval, bradycardia.

Sudden Death in Athletes: What is the role of ECG Screening?

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Professor Sanjay Sharma St George s University of London

27-year-old professionnal rugby player: asymptomatic

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case

R egular intensive physical exercise is associated with an

Value of echocardiography in chronic dyspnea

Introduction. Abbreviations and Definitions

RIGHT VENTRICULAR SIZE AND FUNCTION

Restrictive Cardiomyopathy

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

SABIHA GATI AND SANJAY SHARMA

Risk Factors for Sudden cardiac Death

I have nothing to disclose. Research support from: Cardiac Risk in The Young

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echocardiographie de la Tétralogie de Fallot opérée

Jonathan Kim MD, FACC

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη

Quantitation of right ventricular dimensions and function

Diastolic filling in hypertrophied hearts of elite runners: an Echo-Doppler study

Utility of Echocardiography

Pulmonary Hypertension. Echocardiography: Pearls & Pitfalls

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Diastolic Function Assessment New Guideline Update Practical Approach

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

Mædica - a Journal of Clinical Medicine ORIGIN. How to differentiate athlete s heart from pathological cardiac hypertrophy?

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

HEART CONDITIONS IN SPORT

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Diastolic Heart Function: Applying the New Guidelines Case Studies

Chamber Quantitation Guidelines: What is New?

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Quantification of Cardiac Chamber Size

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou

Sports Cardiology Highlights from EuroPRevent 2012 Dublin

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology

Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Echo Assessment Pre-TAVI

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

Highlights from EuroEcho 2009 Echo in cardiomyopathies

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function

Tricuspid and Pulmonary Valve Disease

SUDDEN CARDIAC DEATH IN ATHLETES

22 nd Annual Conference of the Saudi Heart Association Riyadh, Saudi Arabia

British Society of Echocardiography

Mitral Valve Disease, When to Intervene

Tricuspid and Pulmonary Valve Disease

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J.

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

What s New in Cardiac MRI

3/27/2014. Introduction.

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes. Thomas W. Allen, DO, MPH

Normal ECG And ECHO Findings in Athletes

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Practical Echocardiography: ECHOES in the REAL WORLD Know When to Hold Em and When to Fold Em

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

PRELIMINARY STUDIES OF LEFT VENTRICULAR WALL THICKNESS AND MASS OF NORMOTENSIVE AND HYPERTENSIVE SUBJECTS USING M-MODE ECHOCARDIOGRAPHY

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Ref 1. Ref 2. Ref 3. Ref 4. See graph

좌심실수축기능평가 Cardiac Function

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Transcription:

Paris 2016 ; January 13-16th 26 th European days of the French Society of Cardiology Sports and cardiology: an explosive cocktail? Echographic tricky aspects in the athlete's heart Eric Abergel Clinique Saint-Augustin, Bordeaux

Disclosure Statement of Financial Interest I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company none Daiichi Sankyo, MSD none none none none none

Cardiovascular causes of sudden death in young competitive athletes Maron BJ Circulation 2006;114:1633. USA Most common Hypertrophic CM (33%) Congenital coronary artery anomaly (14%) Less common Myocarditis Valvular heart disease (AS, Mitral prolapse) Atherosclerotic CAD Dilated CM ARVC Aortic rupture (Marfan) Corrado D JACC 2003;42:1959. Italian Most common ARVC (22%) Atherosclerotic CAD (18%) Congenital coronary artery anomaly (13%) Less common Myocarditis Mitral prolapse Premature CAD Dilated CM Hypertrophic CM (2%) Aortic rupture (Marfan)

Echocardiography in athletes: many potential pitfalls These diagnosis can be suspected in healthy athletes Overestimation of wall thickness (doctor!) Interpretation of LVH /other parameters HCM Interpretation of LVEF Interpretation of LV dilation Interpretation of a restrictive LV filling DCM Interpretation of RV dilation ARVC

Thickness: wrong measurement frequent, not innocent Referred for HCM, WT>> 15 mm Overestimation of septal thickness A current etiology of HCM in sport Tricuspid Subvalvular apparatus False chordae tendineae

Thickness: interpretation well codified HCM: Maximal WT 15 mm ; possible with WT 13-14 mm Elliott PM. EHJ 2014;35:2733. 440 FEMALE (age 14-35) 720 M and F (age 14-18) 600 MALE (age 14-35) 3% (8 athletes) 0.4% (3 athletes) 6 3 Rawlins J. Circulation 2010. Sharma. JACC 2002. Basavarajaiah S. JACC 2008. Female Athlete 11 mm white 13 mm black Teenager (14-18 yold) 12 mm men 11 mm women Male Athlete 15 mm white 16 mm black...male adults athletes with maximal LVWT 13-16 mm are in a grey zone Rare: around 2% of athletes, 5% of HCM Maron BJ. Circulation 2006;114:1633.

LVH : HCM or athlete s heart? Wrong measurement is not always a beginner s mistake Solution: don t focus only on wall thickness ; other parameters+++ Large LV cavity Very good LV relaxation Strongly support athlete s heart Question a WT>16 mm

LV cavity size: the most important discriminator between HCM and physiologic LVH 3500 elite athletes (75% male) LVIDd (mm)= 58.5±5.1 (45-65) Among 53 with LVH > 12 mm 50 had dilated LV cavity (>56 mm) Basavarajaiah S. JACC 2008;51:1033. 70 adolescents with HCM No LVD > 48 mm Maron BJ. JAMA 1999;281:650 25 HCM /28 elite athletes LVH Grey zone 13-15 mm Cut-off LV diameter 54 mm Caselli S. Am J Cardiol 2014;114:1383.

LV cavity size: the most important discriminator 286 world class male cyclists (Tour de France) 25 cyclists with Maximal LVWT >13 mm 23 with LVIDd > 55 mm LVIDd (mm) 55 mm 13 mm MaxWT (mm) Abergel E. JACC 2004;44:144.

3D echo: Ratio LVmass/end diastolic volume 152 healthy volunteers ; 19 rowers ; 23 DCM ; 26 HCM 2.40±0.67 HCM 1.12±0.14 Athletes Volunteers 1.03±0.12 DCM 0.55±0.09 De Castro S. Heart 2007;93:205.

Mitral e (Pulsed DTI) e Author Number Subjects e infseptal cm/s e antlateral cm/s Caso 2000 20 Water Polo 13±3 16±4 Claessens 2001 52 Triathletes 16.3±1.7 Cardim 2003 15 Rower 13.3±2.0 18.9±3.4 Butz 2010 100 Hanball 13.2±2.8 16.6±3.4 D Andrea 2010 650 Endurance/power 14±3 16±5 Caselli 2015 1145 All sports 13.8±2.2 ND Geske 2007 100 Sedentary HCM 5.3±1.8 6.8±2.3

E/A ratio and e 1145 Olympic athletes (61% men), 154 controls Caselli S. JASE 2015;28:236. E/A ratio (tip of the leaflets) e septal Athletes: E/A ratio always>1 Athletes: e septal always>8 cm/s Very suspicious All HCM have abnormal relaxation Abnormal relaxation: e sept< 8 cm/s Nagueh SF. JASE 2009 ;22:107.

Global LV longitudinal strain: a false friend? Football (n=28) 12-16 mm Soccer (n=29) <13 mm Caselli S. J Am Soc Echocardiogr 2015;28:245 HCM (n=26) Controls (n=17) GLS% -16.9 ± 4% -16.3 ± 7.7% -21.5 ± 2.0% * Bodybuilders AAS+(n=25) HCM (n=21) Bodybuilders AAS-(n=20) Controls (n=17) GLS% -17 ± 2% -15 ± 3% -18 ± 2% Kansal VM. AJC 2011;108:1322 Olympic Athletes (n=200) Controls (n=50) P value GLS% -18.1±2.2 (-15,-22) -19.4±2.3 (-16,-23) <.001 Richand V. AJC 2007;100:128-132 Controls (n=25) GLS% -15±5** -20±6-19±6 D Andrea A. Br J Sports Med 2007;13:149

HCM or Athlete's heart? Man > 16-18 years old, wall thickness 13-16 mm Athlete's heart LVIDd (> 54..55..56 mm) E/A > 1 always e septal > 8 cm/s always» usually > 13-14 cm/s Normal LV Longitudinal strain» caution: GLS may be low in athletes Normal mitral valve (morphology, position) No outflow obstruction (rest and exercise); possible after exercise HCM LVIDd < 48 mm E/A < 1 e < 8 cm/s Low LV Longitudinal strain Abnormal mitral valve (morphology, position)

What about athletes with HCM vs sedentary HCM - 106 athletes with HCM (14-35 years); 101 sedentary HCM - 15 Moderate HCM athletes vs 55 LVH healthy athletes LVEDD 51 mm (AUC 0.82) e 11 cm/s (AUC 0.88) In athletes with high suspicion for HCM, other non invasive cardiac tests are necessary Sheikh N. Circulation CVI 2015;8:xxx

MRI: the solution? Not always. Compare Echo and MRI in difficult cases

Physiological dilation or dilated cardiomyopathy? 1309 athletes, 38 sports (max impact: endurance cycling, swimming, Rowing, soccer) Majority with LVIDd<60 mm ; 14% with LVIDd>60 mm LVIDd: Men 55 mm (43-70 mm) LVIDd: Women 48 mm (38-66 mm) Follow up to 12 years without symptom Pelliccia. Ann Intern med 1999;130:23 Spirito AJC 1994;74:802 Restrictive mitral inflow is frequent Endurance Combined Strength Controls p Pluim BM Circulation 2000;101:336 59 studies ; 1451 athletes all sports

LVEF (%) 80 75 70 65 60 LV Dilation : how to interpret? Dilation is usual, low LVEF is not rare 286 cyclists participating to the Tour de France (1995 et 1998) 1995 1998 147/286: LVIDd > 60 mm 17/286: LVID>60mm and LVEF<52% 55 50 45 Abergel E. Am Heart J 1998;136:818 Abergel E. JACC 2004;44:144. 40 47.5 50 52.5 55 57.5 60 62.5 65 67.5 70 72.5 75 LVIDd (mm) Suspicion of DCM in athletes: LV Dilation + Low LVEF+ DD Supporting athlete heart: High e ; LV contractile reserve Galderisi M EHJCVI 2015;16:353

Exercise echocardiography American football (static ++ endurance +) 156 athletes, 40% with LVEF between 50 and 55% (low normal) Exercise echo : appropriate hyperdynamic EF (76 ± 14%) Abernethy III JACC 2003;41:280 2015 expert consensus of the European Association of Cardiovascular Imaging Galderisi M EHJCVI 2015;16:353 «Exercise stress echo in athletes with EF < 45 50% at rest to test if there is contractile reserve (=EF increase>70%) during exercise. Rest Exercise

RV dilation: normal adaptation or ARVC? Major ARVC criteria Regional RV akinesia, dyskinesia and RVOTp 32 mm (>19 mm/m 2 ) Marcus F. Circulation 2010;121:1533. 675 consecutive reasonable athletes competing at the regional, national, or international level Zaidi A. Circulation 2013;127:1783.

Adapted RV thresholds are required in athletes Parameter ASE nl 102 (86M) athletes 301 Male athletes 74 Female athletes RVOT Prox LA 33 mm 40 mm (20 mm/m 2 ) 37 mm (21 mm/m 2 ) RV basal diameter 42 mm < 38 mm/(m 2 ) 0.468 55 mm (28 mm/m 2 ) Rudski LG. JASE 2010;23:685. Oxborough D. JASE 2012;25:263. 49 mm (28 mm/m 2 ) Zaidi A. Circulation 2013;127:1783. Zaidi 2013 375 white 300 black Controls RVFAC 42±8% (44±8%) 42±9% (42±9%) S 15±3 cm/s (15±2) S 15±3 cm/s (15±1) La Gerche 2011/2012 79 endurance male Controls RVFAC 52±6% (52±8%) strain basal -22% (- 27%, p=0.018) Similar contractile reserve (exercise echo)

Normal adaptation or ARVC? Parameter Athletes ARVC RV dilation RV function RV Longitudinal strain Predominant RV basal enlargement No wall motion abnormality Normal or low Predominant RVOT enlargement Wall motion abnormality Low Exercise Echo Contractile reserve; nl strain No Contractile reserve LV dilation Yes No dilation RVOT proximal Long axis Dilation 40 mm man 37 mm woman 22 mm/m 2 both sex > 40 mm man > 37 mm woman

Large LVDD > 52-54 mm E/A>1 E > 11-13 cm/s Normal mitral valve No wall motion abnormality Predominant RV basal enlargment Strain nl/low ; Exercise nl HCM WT 13-16 mm Avoid overestimation RVOT 32-40 mm ARVC Athlete Heart Grey Zone DCM LVID 58-70 mm ± Low LVEF at rest Exercise echo: Nl LVEF ± Restrictive mitral flow High E

Left atrium Volume index in highly trained athletes 615 athletes (370 endurance ; 245 strength-trained) D Andrea A. Am H J 2010;159:1155

Other physiological modifications Proportional dilation of both ventricles Echo and MRI study Scharhag J. JACC 2002;40:1856. Inferior vena cava dilation 58 high level athletes, swimmers++» 23 ± 5 mm vs 11 ± 1 mm (30 controls) Goldhammer E. JASE 1999;12:988. Aortic root dilatation very uncommon 0,26% chez 1929 athletes 15-34 years old (basketball) Frequent MR Kinoshita N. AmHJ 2000;139:723. Douglas PS. AJC 1989 ; 64 : 209.

Echocardiographic pitfalls in the diagnosis of HCM Prasad K. Heart 1999;82 (supp III):III8.

Take into account load to interpret FS/LVEF Endurance or combined: Low LVEF at rest is not rare Low preload at rest LVEF (Simpson)= 53% LVd = 58 mm LVs = 42 mm FS = 28% LVEF 45 40 35 30 25 20 0 Lifters Runners Controls 20 40 60 80 100 End-systolic wall stress Professional soccer player Paris Saint Germain season 2001 Colan SD. JACC 1987;9:776.

How can we explain asymmetric RV remodeling? Important increase in pulmonary artery pressure in athletes during exercise REST PEAK EXERCISE Author/ TR gdt controls TR gdt athletes TR gdt controls TR gdt athletes Bossone 1999 26 hockey players 12 mmhg (9-15) 21 mmhg (18-23) 21 mmhg (15-27) 47 mmhg (38-55) La Gerche 2012 40 endurance male 22 ± 4 mmhg 22±4 mmhg 47±7 mmhg 61±13 mmhg Pressure excess counterbalanced by reduction in cavity and/or increase in wall thickness? (T=P r/h) La Gerche A. Med Sci Sports Exerc 2011;43:974

Echo: similar RV and LV remodeling in endurance athletes? 127 endurance athletes: cardiac enlargement occurs symmetrically in both right and left cavities Henriksen. Eur Heart J 1996;25:263. RV LV 102 endurance athletes Asymetric enlargement. Normality threshold for RV/LV ratio < 1.17 Oxborough D. JASE 2012;25:263.

How can we explain asymmetric RV remodeling 39 endurance athletes, 14 non athletes MRI (Ventricular size r and thickness h ), Exercise echo (SPAP) ESS (SPAP x r/2h) LV RV Exercise induces a relative increase in RVES-stress which exceeds LVES-stress. In athletes, greater RV enlargement and greater wall thickening may be a product of this disproportionate load excess. La Gerche A. Med Sci Sports Exerc 2011;43:974